
Elinzanetant Reduces VMS in Breast Cancer (OASIS-4)
Elinzanetant Demonstrates Significant Reduction in Hot Flashes for Breast Cancer Patients Undergoing Endocrine Therapy: Results from Phase III OASIS-4 Trial In a major advancement for women experiencing treatment-induced menopausal symptoms, detailed findings from the international Phase III OASIS-4 clinical study…












